Sorrento Therapeutics Expands Resiniferatoxin (RTX) Clinical Development Program to Life-Threatening Cardiovascular Diseases With Completion of Major Animal Toxicology Study
April 15, 2019 04:00 ET
|
Sorrento Therapeutics, Inc.
SAN DIEGO, April 15, 2019 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (NASDAQ: SRNE, "Sorrento"), announced that its Neuro-Therapeutics unit is pursuing clinical development of resiniferatoxin...
Non-Alcoholic Steatohepatitis (NASH) Market To Reach USD 13.38 Billion By 2026 | Reports And Data
February 27, 2019 08:33 ET
|
Reports And Data
Increasing prevalence of obesity coupled with rising adoption of sedentary lifestyle is the major factor influencing market growth. Market Size – USD 0.41 billion in 2018, Market Growth - CAGR of...
Canadian company proves exercise is a miracle drug
November 22, 2018 12:23 ET
|
LIVE WELL Exercise Clinic
Gym members see significant reductions in blood pressure, weight within 6 months of joining powerful exercise and healthy lifestyle coaching program VANCOUVER, British Columbia, Nov. 22, 2018 ...
Marina Biotech Appoints Jay D. Schwartz to serve as Senior Vice President, Commercial Operations
August 06, 2018 09:15 ET
|
Marina Biotech, Inc.
City of Industry, CA, Aug. 06, 2018 (GLOBE NEWSWIRE) -- Marina Biotech, Inc. (OTCQB: MRNA), a commercial stage pharmaceutical company focused on the development and commercialization of...
Naturopathic Doctors Offer Non-Drug Approaches to Manage Hypertension
August 01, 2018 09:00 ET
|
Institute for Natural Medicine
Seattle, Aug. 01, 2018 (GLOBE NEWSWIRE) -- New guidelines from the American Heart Association mean that nearly one out of every two American adults with high blood pressure may be facing a choice...
Stanford Nephrology Fellow Katherine M. Wang Named American Kidney Fund Clinical Scientist in Nephrology
July 10, 2018 15:47 ET
|
American Kidney Fund
ROCKVILLE, Md., July 10, 2018 (GLOBE NEWSWIRE) -- Katherine M. Wang, M.D., a second-year nephrology fellow at Stanford University, has been named the American Kidney Fund (AKF) Clinical Scientist...
WellDoc®’s BlueStar® Now Available for Hypertension and Weight Management
July 09, 2018 09:00 ET
|
WellDoc Inc.
BALTIMORE, July 09, 2018 (GLOBE NEWSWIRE) -- WellDoc®, a leading digital health company, today announces hypertension and weight management solutions integrated within its digital therapeutic app...
UPMC PINNACLE PARTICIPATING IN GROUNDBREAKING TRIAL TO HELP LOWER BLOOD PRESSURE
May 09, 2018 09:00 ET
|
UPMC Pinnacle
HARRISBURG, PA, May 09, 2018 (GLOBE NEWSWIRE) -- UPMC Pinnacle today announced it is enrolling patients to participate in a study of an investigational medical device that aims to help lower blood...
Marina Biotech Appoints Chief Legal Officer to Support Legal, Transactional and Intellectual Property Portfolio Initiatives
October 19, 2017 08:30 ET
|
Marina Biotech, Inc.
City of Industry, CA, Oct. 19, 2017 (GLOBE NEWSWIRE) -- Marina Biotech, Inc. (OTCQB: MRNA), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics...
Marina Biotech Appoints Amit Shah as Chief Financial Officer
October 05, 2017 08:30 ET
|
Marina Biotech, Inc.
City of Industry, CA, Oct. 05, 2017 (GLOBE NEWSWIRE) -- Marina Biotech, Inc. (OTCQB: MRNA), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics...